Archangels has backed Earth Blox in a £1.5m seed round to support product development and market expansion.
"We are very pleased to secure this funding from Archangels and join a strong portfolio of businesses in the life sciences and tech sectors. Investment into innovative businesses like ours is vital to growth in all areas, from customer acquisition to building a great team. This investment will help us develop Earth Blox as a scalable SaaS and get the power of Earth observation insights into the hands of a range of users around the world."
The round was led by F-Prime Capital to support the development of novel therapeutics for disordered proteins.
"By taking a rigorous and computer-driven experimental physics approach to analysing proteins, we can go beyond classical drug discovery approaches and observe protein behaviour that algorithms like AlphaFold cannot. This new funding will allow us to further advance our platform and support the investigation of the disordered protein universe towards developing drugs of the future,"
The Series A round was led by ACT Venture Partners and SuperSeed to scale operations and product development.
"We were thrilled with the team’s achievements in developing and validating their platform with leading global customers from the automotive, aerospace, energy and construction sectors. Ai Build’s clear vision to enable faster, repeatable and sustainable additive manufacturing through AI and automation is a game changer in scaling production, and making Ai Build the default operating system for all additive machines will be key in their growth strategy"
The Series A round was led by Octopus Ventures, Oxford Science Enterprises, Quantonation, and Verve Ventures.
"Light has a huge part to play in the future of quantum computing as an effective, scalable resource. Our mission is to put photonic systems in the hands of users today so that we deliver value in the short as well as long term,"